: Biogen to slash 1,000 jobs as it looks to save $700 million

Biotech giant’s cost-cutting effort comes amid the launch of its Alzheimer’s treatment, Leqembi.

Previous post Home prices continue to climb with ‘striking’ regional differences, says S&P Case-Shiller
Next post The Ratings Game: Meta’s stock picks up an upgrade ahead of earnings — but AI is the biggest driver